A device that analyzes blood levels of prostate-specific antigen (PSA) is one of the first doctor’s-office uses of microfluidics–technology that can manipulate fluids on a chip at microscopic scales. When a cartridge bearing a blood sample is inserted into the tabletop device, an accurate reading can be completed in 15 minutes, helping monitor the health of patients with prostate cancer. The procedure used now involves sending a sample to a lab for analysis, which often takes a day or two. The device received European approval in June.
Credit: Christopher Harting
Product: Claros DX 1
Cost: To be announced in late 2010
Availability: Late 2010 in selected European markets
Other products in this section:
Become an Insider to get the story behind the story — and before anyone else.
A Cheap and Easy Blood Test Could Catch Cancer Early
50,000 healthy people will be screened in an effort to detect hidden tumors.
U.S. Doctors Plan to Treat Cancer Patients Using CRISPR
Gene-edited immune cells could help wipe out deadly tumors.
Gene Therapy Could Make Cancer Care More Unequal, and This Map Shows Why
Revolutionary new cancer treatments won’t be available in many rural areas of the U.S.